Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / GPC3 대상으로 Bispecific 항 체, GPC3-S-팹, 강력한 세포…
JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content.

JoVE Journal Cancer Research
GPC3 대상으로 Bispecific 항 체, GPC3-S-팹, 강력한 세포 독성을
Analysis of Side Population in Solid Tumor Cell Lines
Journal (Cancer Research)
Analysis of Side Population in Solid Tumor Cell Lines
Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Journal (Cancer Research)
Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
 
Click here for the English version

GPC3 대상으로 Bispecific 항 체, GPC3-S-팹, 강력한 세포 독성을

Article DOI: 10.3791/57588-v • 11:13 min • July 12th, 2018
July 12th, 2018 •
1,2, 1,2, 1,2, 1,2, 1,2, 1,2, 1,2
1School of Pharmaceutical Sciences, Sun Yat-Sen University, 2Center for Cellular & Structural Biology, Sun Yat-Sen University

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

여기, 우리 제시에 bispecific 항 체 GPC3-S-팹 생산 프로토콜 대장균. 순화 GPC3-S-팹 GPC3 긍정적인 간 암 세포에 대 한 강력한 세포 독성을 있다.

Tags

암 연구 문제 137 Bispecific 항 체 항 체 단일 도메인 VHH GPC3-S-팹 GPC3 간 암
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter